Avadel Pharmaceuticals (AVDL) Accumulated Depreciation & Amortization (2016 - 2021)
Historic Accumulated Depreciation & Amortization for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Q4 2020 value amounting to $1.1 million.
- Avadel Pharmaceuticals' Accumulated Depreciation & Amortization rose 5182.07% to $1.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.1 million, marking a year-over-year increase of 5182.07%. This contributed to the annual value of $1.1 million for FY2020, which is 5182.07% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Accumulated Depreciation & Amortization of $1.1 million as of Q4 2020, which was up 5182.07% from $714000.0 recorded in Q4 2019.
- Avadel Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $7.1 million for Q4 2017, and its period low was $714000.0 during Q4 2019.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $5.7 million (2016), whereas its average is $4.3 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 8973.11% in 2019, then soared by 5182.07% in 2020.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Accumulated Depreciation & Amortization stood at $5.7 million in 2016, then increased by 25.18% to $7.1 million in 2017, then fell by 2.54% to $7.0 million in 2018, then plummeted by 89.73% to $714000.0 in 2019, then soared by 51.82% to $1.1 million in 2020.
- Its last three reported values are $1.1 million in Q4 2020, $714000.0 for Q4 2019, and $7.0 million during Q4 2018.